SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001616824-24-000043
Filing Date
2024-02-08
Accepted
2024-02-08 10:47:16
Documents
1
Period of Report
2024-02-07

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 2785
  Complete submission text file 0001616824-24-000043.txt   4175
Mailing Address 156 S. FIRST STREET ZIONSVILLE IN 46077
Business Address
Leonard Braden Michael (Reporting) CIK: 0001373603 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37581 | Film No.: 24607524

Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)